ClinicalTrials.gg
Enrolling by invitationNCT02702869ACCQUIREnetUpdated Jan 7, 2026

Allied Cleft & Craniofacial Quality-Improvement and Research Network (ACCQUIREnet)

An observational study in Cleft Lip, Cleft Palate and Cleft Lip and Palate, sponsored by Duke University. Enrolling by invitation at 11 sites in 2 countries. Open to participants aged 1 Day to 22 Years. Per ClinicalTrials.gov, last updated 2026-01-07.

Sponsored by Duke University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Ages
1 Day to 22 Years
Sex
All
01

Study summary

The Allied Cleft \& Craniofacial Quality-Improvement and Research Network (ACCQUIREnet) is a group of multidisciplinary cleft teams that have implemented a system for prospective collection of outcomes data, based on the ICHOM Standard Set for the Comprehensive Appraisal of Cleft Care, CLEFT-Q, and other outcomes instruments. Participating cleft teams may analyze clinical and psychosocial outcomes related to care of the child with cleft lip and/or palate (CL/P), compare its performance with those of other cleft centers, and identify opportunities for quality improvement.

Read the detailed description

The purpose of this project is to implement a system of prospective, standardized data collection for all patients with cleft lip and/or palate (CL/P) treated by the cleft and craniofacial centers that participate in ACCQUIREnet.

Adoption of this prospective data-collection system has two principal goals:

  1. To enable on-demand and scheduled review of cleft-care-related safety and outcomes data and team performance for the purpose of internal audits and continuous quality improvement; and
  2. To permit participation in multi-site, collaborative quality-improvement projects and/or research networks that require usage of these standardized data-collection methods. (These collaborations are described in corresponding IRB protocols and data-transfer agreements. Patient privacy and confidentiality is protected at all times.)

All patients with CL/P treated at cleft and craniofacial centers participating in ACCQUIREnet will be invited to participate in this project. Duke University serves as the coordinating center and statistical support center for the study. Data are maintained in a local, secured database.

The IRB protocol details methods of quality assurance, data monitoring, and auditing. Data dictionaries employed in ACCQUIREnet include the CleftCap REDCap project template, CleftKit Common Data Model (an extension of the PCORnet Common Data Model), the ICHOM Standard Set for the Comprehensive Appraisal of Cleft Care, and the CLEFT-Q patient-reported outcome manual, maintained by the International Consortium for Health Outcomes Measurement (ichom.org) and McMaster University, respectively.

02

Conditions studied

  • Cleft Lip
  • Cleft Palate
  • Cleft Lip and Palate

Keywords

  • cleft lip
  • cleft palate
  • cleft lip and palate
  • cleft alveolus
  • multidisciplinary team
  • interdisciplinary team
03

In context

Cleft Lip

168 studies on the registry are indexed under Cleft Lip; 51 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 100 across 49 observational studies indexed under Cleft Lip.

Browse Cleft Lip studies →

Lead sponsor

Duke University is the lead sponsor of 2,063 studies on the registry; 273 are open to participants now.

Of its 204 completed or terminated interventional studies of FDA-regulated products, 167 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 22 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients born with cleft lip and/or palate are eligible for inclusion in this study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Typical orofacial clefts, of which subtypes are:
  • Unilateral or bilateral cleft lip
  • Unilateral or bilateral cleft lip and alveolus
  • Unilateral or bilateral cleft lip and alveolus and palate
  • Unilateral or bilateral cleft lip and palate
  • Overt cleft palate
  • Occult cleft palate

Exclusion criteria

Exclusion Criteria:

  • Atypical (Tessier) facial clefts
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Target follow-up
22 Years
Patient registry
Yes

Groups and cohorts

  • uCL(A)

    Children with unilateral cleft lip with/without cleft alveolus but intact secondary palate. Subgroup analysis by severity of lip (complete, incomplete, or lesser-form).

    Procedure: cleft lip repair · Procedure: gingivoperiosteoplasty · Procedure: LeFort-1 maxillary repositioning · Procedure: rhinoplasty · Other: speech therapy · Procedure: orthodontia · Procedure: presurgical orthopedics

  • uCL(A)P

    Children with unilateral cleft lip with/without cleft alveolus and with cleft secondary palate. Subgroup analysis by severity of lip (complete, incomplete, or lesser-form) and severity of palate (submucous, Veau-I, Veau-II, or Veau-III).

    Procedure: cleft lip repair · Procedure: cleft palate repair · Procedure: oronasal fistula repair · Procedure: pharyngoplasty · Procedure: gingivoperiosteoplasty · Procedure: LeFort-1 maxillary repositioning · Procedure: rhinoplasty · Procedure: myringotomy and tympanostomy tube placement · Other: speech therapy · Procedure: orthodontia · Procedure: presurgical orthopedics · Device: sound amplification for hearing

  • bCL(A)

    Children with bilateral cleft lip with/without cleft alveolus but intact secondary palate. Subgroup analysis by severity of lip (complete, incomplete, or lesser-form).

    Procedure: cleft lip repair · Procedure: gingivoperiosteoplasty · Procedure: LeFort-1 maxillary repositioning · Procedure: rhinoplasty · Other: speech therapy · Procedure: orthodontia · Procedure: presurgical orthopedics

  • bCL(A)P

    Children with unilateral cleft lip with/without cleft alveolus and with cleft secondary palate. Subgroup analysis by severity of lip (complete, incomplete, or lesser-form) and severity of palate (submucous, Veau-I, Veau-II, Veau-III, or Veau-IV).

    Procedure: cleft lip repair · Procedure: cleft palate repair · Procedure: oronasal fistula repair · Procedure: pharyngoplasty · Procedure: gingivoperiosteoplasty · Procedure: LeFort-1 maxillary repositioning · Procedure: rhinoplasty · Procedure: myringotomy and tympanostomy tube placement · Other: speech therapy · Procedure: orthodontia · Procedure: presurgical orthopedics · Device: sound amplification for hearing

  • CP

    Children with cleft secondary palate only, but intact lip and alveolus. Subgroup analysis by severity (submucous, Veau-I, or Veau-II).

    Procedure: cleft palate repair · Procedure: oronasal fistula repair · Procedure: pharyngoplasty · Procedure: LeFort-1 maxillary repositioning · Procedure: myringotomy and tympanostomy tube placement · Other: speech therapy · Device: sound amplification for hearing

Interventions

  • Procedurecleft lip repair

    Also known as: cheiloplasty

  • Procedurecleft palate repair

    Also known as: palatoplasty

  • Procedureoronasal fistula repair
  • Procedurepharyngoplasty

    Also known as: sphincteroplasty

  • Proceduregingivoperiosteoplasty
  • ProcedureLeFort-1 maxillary repositioning

    Also known as: orthognathic surgery

  • Procedurerhinoplasty
  • Proceduremyringotomy and tympanostomy tube placement
  • Otherspeech therapy
  • Procedureorthodontia
  • Procedurepresurgical orthopedics

    Also known as: nasoalveolar molding, dentofacial orthopedics, Georgiade-Latham appliance, Latham appliance

  • Devicesound amplification for hearing

    Also known as: hearing aid

06

What researchers measure

Primary outcomes

  1. Speech: intelligibility

    Utilizes the intelligibility in context scale (ICS)

    Time frame: ~5 years of age

  2. Speech: intelligibility

    Utilizes the intelligibility in context scale (ICS)

    Time frame: ~8 years of age

  3. Speech: intelligibility

    Utilizes the intelligibility in context scale (ICS)

    Time frame: ~12 years of age

  4. Speech: intelligibility

    Utilizes the intelligibility in context scale (ICS)

    Time frame: ~22 years of age

  5. Speech: velopharyngeal competence

    Time frame: ~5 years of age

  6. Speech: velopharyngeal competence

    Time frame: ~8 years of age

  7. Speech: velopharyngeal competence

    Time frame: ~12 years of age

  8. Speech: velopharyngeal competence

    Time frame: ~22 years of age

  9. Speech: articulation

    Utilizes the modified percent correct consonants (mPCC) scale

    Time frame: ~5 years of age

  10. Speech: articulation

    Utilizes the modified percent correct consonants (mPCC) scale

    Time frame: ~8 years of age

  11. Speech: articulation

    Utilizes the modified percent correct consonants (mPCC) scale

    Time frame: ~12 years of age

  12. Speech: articulation

    Utilizes the modified percent correct consonants (mPCC) scale

    Time frame: ~22 years of age

  13. Speech: patient-reported outcomes related to speech and speaking

    Utilizes the CLEFT-Q PROM

    Time frame: ~8 years of age

  14. Speech: patient-reported outcomes related to speech and speaking

    Utilizes the CLEFT-Q PROM

    Time frame: ~12 years of age

  15. Speech: patient-reported outcomes related to speech and speaking

    Utilizes the CLEFT-Q PROM

    Time frame: ~22 years of age

  16. Hearing: puretone average

    Time frame: ~5 years of age

  17. Dental: dmft and DMFT scores

    Utilizes the dmft score for deciduous teeth and DMFT score for permanent teeth

    Time frame: ~5 years of age

  18. Dental: dmft and DMFT scores

    Utilizes the dmft score for deciduous teeth and DMFT score for permanent teeth

    Time frame: ~12 years of age

  19. Dental: dmft and DMFT scores

    Utilizes the dmft score for deciduous teeth and DMFT score for permanent teeth

    Time frame: ~22 years of age

  20. Dental: occlusion (Uses modifications of the GOSLON scale)

    Time frame: ~5 years of age

  21. Dental: occlusion (Uses modifications of the Bauru scale)

    Time frame: ~5 years of age

  22. Dental: occlusion (Uses modifications of the GOSLON scale)

    Time frame: ~12 years of age

  23. Dental: occlusion (Uses modifications of the Bauru scale)

    Time frame: ~12 years of age

  24. Dental: occlusion (Uses modifications of the GOSLON scale)

    Time frame: ~22 years of age

  25. Dental: occlusion (Uses modifications of the Bauru scale)

    Time frame: ~22 years of age

  26. Dental: patient-reported outcomes related to mastication

    Uses the CLEFT-Q PROM

    Time frame: ~8 years of age

  27. Dental: patient-reported outcomes related to mastication

    Uses the CLEFT-Q PROM

    Time frame: ~12 years of age

  28. Dental: patient-reported outcomes related to mastication

    Uses the CLEFT-Q PROM

    Time frame: ~22 years of age

  29. Dental: patient-reported outcomes related to oral health

    Uses the COHIP PROM

    Time frame: ~8 years of age

  30. Dental: patient-reported outcomes related to oral health

    Uses the COHIP PROM

    Time frame: ~12 years of age

  31. Dental: patient-reported outcomes related to oral health

    Uses the COHIP PROM

    Time frame: ~22 years of age

  32. Patient-reported outcomes related to eating/drinking

    Uses the CLEFT-Q PROM

    Time frame: ~8 years of age

  33. Patient-reported outcomes related to eating/drinking

    Uses the CLEFT-Q PROM

    Time frame: ~12 years of age

  34. Patient-reported outcomes related to eating/drinking

    Uses the CLEFT-Q PROM

    Time frame: ~22 years of age

  35. Breathing: Patient-reported outcomes related to nasal and oral breathing

    Uses the NOSE PROM

    Time frame: ~8 years of age

  36. Breathing: Patient-reported outcomes related to nasal and oral breathing

    Uses the NOSE PROM

    Time frame: ~12 years of age

  37. Breathing: Patient-reported outcomes related to nasal and oral breathing

    Uses the NOSE PROM

    Time frame: ~22 years of age

  38. Aesthetics: Patient-reported outcomes related to appearance

    Uses the CLEFT-Q PROM

    Time frame: ~8 years of age

  39. Aesthetics: Patient-reported outcomes related to appearance

    Uses the CLEFT-Q PROM

    Time frame: ~12 years of age

  40. Aesthetics: Patient-reported outcomes related to appearance

    Uses the CLEFT-Q PROM

    Time frame: ~22 years of age

  41. Aesthetics: Clinical assessment of nasolabial and facial aesthetics

    Time frame: ~2 years of age

  42. Aesthetics: Clinical assessment of nasolabial and facial aesthetics

    Time frame: ~5 years of age

  43. Aesthetics: Clinical assessment of nasolabial and facial aesthetics

    Time frame: ~8 years of age

  44. Aesthetics: Clinical assessment of nasolabial and facial aesthetics

    Time frame: ~12 years of age

  45. Aesthetics: Clinical assessment of nasolabial and facial aesthetics

    Time frame: ~22 years of age

07

Study locations

11 sites
  • University of Florida - Shands Hospital
    Gainesville, Florida 32608, United States
  • Joe DiMaggio Children's Hospital
    Hollywood, Florida 33021, United States
  • Orlando Health - Arnold Palmer Hospital for Children
    Orlando, Florida 32806, United States
  • Johns Hopkins - All Children's Hospital (JHACH)
    St. Petersburg, Florida 33701, United States
  • Maine Medical Center
    Portland, Maine 04102, United States
  • Harvard University - Boston Children's Hospital (BCH)
    Boston, Massachusetts 02115, United States
  • Washington University - St. Louis Children's Hospital (WUSTL)
    St Louis, Missouri 63110, United States
  • Duke University - Duke Children's Hospital & Health Center
    Durham, North Carolina 27710, United States
  • Wake Forest University - Brenner Children's Hospital
    Winston-Salem, North Carolina 27157, United States
  • University of Texas at Houston - Children's Memorial Hermann Hospital
    Houston, Texas 77030, United States
  • Dalhousie University - IWK Health Centre
    Halifax, Nova Scotia B3K 6R8, Canada
08

References and documents

Individual participant data

Plan to share: No — This is a collaborative research network. All data processing happens at the coordinating center, with results reviewed by the participating centers.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2016 (actual). Primary completion is estimated for Dec 2031, 182 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 16, 2015
First posted
Mar 9, 2016
StartActual
Oct 2016
Primary completionEst.
Dec 2031
CompletionEst.
Dec 2031
Last update
Jan 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02702869
Lead sponsor
Duke University
Responsible party
Sponsor
First posted
Mar 9, 2016
Start date
Oct 2016
Primary completion
Dec 2031 (estimated)
Completion
Dec 2031 (estimated)
Last update
Jan 7, 2026

Study contacts

Alexander C Allori, MD, MPH
principal investigator · Duke University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion